As<unk>  is thought to be metabolized by the liver enzymes CYP3A4 and CYP2C19, use of moderate to strong CYP3A4 inhibitors (such as grapefruit juice) and of the CYP2C19 inhibitor fluconazole is discouraged for people taking<unk> .
Selumetinib
Binimetinib
Cobimetinib
Pralsetinib
Lestaurtinib
Axitinib
Mobocertinib
Gefitinib